Katarzyna Jaworska-Bieniek

Polish molecular biologist

Katarzyna Jaworska-Bieniek is …
instance of (P31):
humanQ5

External links are
P7293PLWABN ID9810626568905606
P3124Polish scientist ID (deprecated)251423
P214VIAF ID317161347

P27country of citizenshipPolandQ36
P184doctoral advisorAnna JakubowskaQ58323317
P734family nameBieniekQ15948541
BieniekQ15948541
BieniekQ15948541
JaworskaQ47191882
JaworskaQ47191882
JaworskaQ47191882
P735given nameAgnieszkaQ16161911
AgnieszkaQ16161911
KatarzynaQ17318005
KatarzynaQ17318005
P1412languages spoken, written or signedPolishQ809
P1559name in native languageKatarzyna Jaworska-Bieniek
P103native languagePolishQ809
P106occupationresearcherQ1650915
molecular biologistQ15839206
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q60684176Abstract LB-159: Methylation of BRCA1 gene in blood is not inherited via maternal germ line and may predispose to triple-negative or medullary breast cancer
Q35618307An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
Q55340907Arsenic (As) and breast cancer risk.
Q35242849Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
Q35957703Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
Q90414420Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population
Q35523236Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Q36466697BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
Q112162492CHAPTER 22. Selenium and Cancer
Q46658012Can selenium be a modifier of cancer risk in CHEK2 mutation carriers?
Q34693954Can selenium levels act as a marker of colorectal cancer risk?
Q34963894Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q45906878Copper as diagnostic marker of cancers.
Q21144874DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37594336FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Q36087170Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q36014067Identification of novel genetic markers of breast cancer survival
Q37410472Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q46130512Iron as diagnostic marker of cancer.
Q61818385Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence
Q46130429Magnesium as a diagnostic marker of cancer.
Q47133182Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.
Q50233852Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.
Q85921942Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q46130604Microelements as diagnostic markers of pancreatic cancer.
Q98240553Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q35665705Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q38359733Selenium as a marker of cancer risk and of selection for control examinations in surveillance
Q46130885Selenium as diagnostic marker of cancers.
Q48273027Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence
Q37097470Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer
Q54487901Serum concentrations of Cu, Se, Fe and Zn in patients diagnosed with pancreatic cancer.
Q33664315Serum folate concentration and the incidence of lung cancer
Q92341152Serum selenium level and cancer risk: a nested case-control study
Q53849040The influence of selenium concentration and variations in selenoprotein genes on the CHEK2-dependent cancers.
Q46660029Zinc and breast cancer risk
Q45946070Zinc as diagnostic marker of cancers.

Q58323317Anna Jakubowskadoctoral studentP185

Search more.